Hepatitis C genotype 4: Genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia

Saudi Journal of Gastroenterology

Volumn 19, Issue 1, 2013, Pages 28-33

  Al Ashgar, Hamad ^a   Khan, Mohammed ^a   Al Ahdal, Mohammed ^a   Al Thawadi, Sahar ^b   Helmy, Ahmad ^a,b   Al Qahtani, Ahmed ^a,c   Sanai, Faisal ^b,d  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b Research Center   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

Author keywords

HCV genotype 4; Hepatitis C virus; subtypes of HCV 4

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; FEMALE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C GENOTYPE 4; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SAUDI ARABIA; TREATMENT RESPONSE; VIRUS TRANSMISSION;

ADULT; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MORBIDITY; RETROSPECTIVE STUDIES; RNA, VIRAL; SAUDI ARABIA;

EID: 84873595893     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.105920     Document Type: Article

References (40)

1. World Health Organization. Hepatitis C. WHO fact sheet 164. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/print. html [Last accessed on 2007 May 21].
2. Abdo AA, Sanai FM, Al-Faleh FZ. Epidemiology of viral hepatitis in Saudi Arabia: Are we off the hook? Saudi J Gastroenterol 2012;18:349-57.
3. Bashawri LA, Fawaz NA, Ahmad MS, Qadi AA, Almawi WY. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001. Clin Lab Haematol 2004;26:225-8. (Pubitemid 38736867)
4. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J 2004;25:26-33. (Pubitemid 38262504)
5. Shobokshi OA, Serebour FE, Al-Drees AZ, Mitwalli AH, Qahtani A, Skakni LI. Hepatitis C virus seroprevalence rate among Saudis. Saudi Med J 2003;24:81-6.
6. Osoba AO, Ibrahim M, Abdelaal MA, Al-Mowallad A, Al Shareef B, Hussein BA. Hepatitis C virus genotyping by polymerase chain reaction and DNA enzyme immunoassay among Saudi patients in the Western Province, Saudi Arabia. Ann Saudi Med 2000;20:394-7. (Pubitemid 32851340)
7. Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos HCV sequence database. Bioinformatics 2005;21:379-84. (Pubitemid 40246609)
8. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-73. (Pubitemid 41401136)
9. Abdel Hamid M, El Daly M, Molnegren V, El-Kafrawy S, Abdel-Latif S, Esmat G, et al. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. J Gen Virol 2007;88:1526-31. (Pubitemid 46723235)
10. van Asten L, Verhaest I, Lamzira S, Hernandez-Aguado I, Zangerle R, Boufassa F, et al. Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis. J Infect Dis 2004;189:292-302. (Pubitemid 38147254)
11. Chlabicz S, Flisiak R, Kowalczuk O, Wiercińska-Drapalo A, Pytel- Krolczuk B, Prokopowicz D, et al. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in North-Eastern Poland. J Med Virol 2008;80:615-18. (Pubitemid 351358558)
12. Al Ashgar H, Helmy A, Khan MQ, Al Kahtani K, Al Quaiz M, Rezeig M, et al. Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4. Ann Saudi Med 2009;29:4-14.
13. Al-Qahtani AA, Rubino S, Al-Ahdal MN. Sequence variation of the HVR1 region of Hepatitis C virus in response to interferon-〈 and ribavirin treatment. J Infect Dev Ctries 2011;5:370-6.
14. Murphy DG, Willems B, Deschênes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences. J Clin Microbiol 2007;45:1102-12. (Pubitemid 46626471)
15. Schreier E, Roggendorf M, Driesel G, Hohne M, Viazov S. Genotypes of hepatitis C virus isolates from different parts of the world. Arch Virol 1996;11:185-93. (Pubitemid 126446190)
16. Al-Ahdal MN, Rezeig MA, Kessie G. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome. Ann Saudi Med 1997;17:601-4. (Pubitemid 28264012)
17. Boriskin YS, Bakir TM, al-Aska AI, Booth JC. Is hepatitis C virus genotype 4 predominant in Saudi Arabia? New Microbiol 1999;22:173-80. (Pubitemid 129572814)
18. Osoba AO. Hepatitis C virus genotype in Saudi Arabia. Saudi Med J 2002;23:7-12. (Pubitemid 34187712)
19. Fakeeh M, Zaki AM. Hepatitis C: Prevalence and common genotype among ethic groups in Jeddah, Saudi Arabia. Am J Trop Med Hyg 1999;61:889-92. (Pubitemid 30084108)
20. Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol 1999;58:44-8. (Pubitemid 29172119)
21. Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, et al. Evaluation of Versant hepatitis C virus genotype assay (LiPA-2). J Clin Microbiol 2008;46:1901-6. (Pubitemid 351831817)
22. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 2003;109:187-93. (Pubitemid 36507107)
23. Cantaloube JF, Laperche S, Gallian P, Bouchardeau F, de Lamballerie X, de Micco P. Analysis of the 50 noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France. J Clin Microbiol 2003;44:2051-6.
24. Elkady A, Tanaka Y, Kurbanov F, Sugauchi F, Sugiyama M, Khan A, et al. Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication. J Med Virol 2009;81:1015-23.
25. Tanaka Y, Agha S, Saudy N, Kurbanov F, Orito E, Kato T, et al. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004;58:191-5. (Pubitemid 38183970)
26. Saeed AA, al-Admawi AM, al-Rasheed A, Fairclough D, Bacchus R, et al. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991;338:459-60.
27. Magder LS, Fix AD, Mikhail NN, Mohamed MK, Abdel-Hamid M, Abdel-Aziz F, et al. Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data. Int J Epidemiol 2005;34:60-165.
28. Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, et al. Sexual transmission of HCV between spouses. Am J Gastroenterol 2005;100:821-4. (Pubitemid 40592372)
29. Arif M, al-Swayeh M, al-Faleh FZ, Ramia S. Risk of hepatitis C virus infection among household contacts of Saudi patients with chronic liver disease. J Viral Hepat 1996;3:97-101. (Pubitemid 126734190)
30. Tariq AM. Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia. Trans R Soc Trop Med Hyg. 2009;103:132-6.
31. Nicot F, Legrand-Abravanel F, Sandres-Saune K, Boulestin A, Dubois M, et al. Heterogeneity of hepatitis C virus genotype 4 strains circulating in south-western France. J Gen Virol 2005;86,107-114. (Pubitemid 40081155)
32. Eriksen MB, Jørgensen LB, Krarup H, Laursen AL, Christensen PB, Møller A, et al. Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark. J Med Virol 2010;82:1869-77.
33. de Bruijne J, Schinkel J, Prins M, Koekkoek SM, Aronson SJ, van Ballegooijen MW, et al. Emergence of hepatitis C virus genotype 4: Phylogenetic analysis reveals three distinct epidemiological profiles. J Clin Microbiol 2009;47:3832-8.
34. Calado RA, Rocha MR, Parreira R, Piedade J, Venenno T, Esteves A. Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal. J Med Virol 2011;83:608-15.
35. Fernández-Arcás N, López-Siles J, Trapero S, Ferraro A, Ibáñez A, Orihuela F, et al. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses. J Med Virol 2006;78:1429-35. (Pubitemid 44533871)
36. Katsoulidou A, Sypsa V, Tassopoulos NC, Boletis J, Karafoulidou A, Ketikoglou I, et al. Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates. J Viral Hepat 2006;13:19-27.
37. Roulot D, Bourcier V, Grando V, Deny P, Baazia Y, Fontaine H, et al. Observational VHC4 Study Group. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection. J Viral Hepat 2007;14:460-7. (Pubitemid 46944469)
38. Serpaggi J, Chaix ML, Batisse D, Dupont C, Vallet-Pichard A, Fontaine H, et al. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy. AIDS 2006;20:233-40.
39. Legrand-Abravanel F, Colson P, Leguillou-Guillemette H, Alric L, Ravaux I, Lunel-Fabiani F, et al. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy. J Med Virol 2009;81:2029-35.
40. Nicot F, Alric L, Barange K, Métivier S, Dramard JM, Combis JM, et al. Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy. J Med Virol 2011;83:437-44.